COVID-19 Johns Hopkins Clinical Research Coordinating Committee
We appreciate that many Johns Hopkins faculty and staff are using all of their knowledge and creativity to address this pandemic. At the same time, we need to recognize that those with the disease cannot be asked to be part of multiple protocols that are burdensome and duplicative.
The rationale for coordinating COVID-19 clinical research include:
- Risks to patients, study participants, and staff during the pandemic.
- Patients with COVID-19 presenting to hospitals and facilities across the Johns Hopkins Health System are being cared for by newly formed clinical teams.
- Enhance research participation across the health system to inform the development of evidence-based means of treating COVID-19.
- Not overwhelm patients with multiple requests regarding research participation.
- The need to be sensitive to rapidly emerging data (interventions and the contours of the pandemic).
- The opportunity to learn from different expertise.
- Limits to the number of treatment trials we can support in terms of the number of patients with COVID-19 that meet inclusion/exclusion criteria and resources needed to open, maintain and successfully complete clinical trials.
- Our commitment that patients participate in research that is likely to yield interpretable results.
- Prioritize which protocols will receive university support, including review by the IRB.
- Prioritize supplies for non-essential resources such as PPE and reagent or specimen collection and transfer materials.
- Use resources efficiently.
Please visit each of the sections below to learn about the review process.